RDEP is a sign that regulators acknowledge that rare disease is a unique space that requires special attention.
Laksheeta Johari
Advertisement
Laksheeta Johari is an analyst for Lifescience Dynamics.
Articles by Laksheeta Johari
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
2
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
3
How Does FDA's Single Trial Decision Change The Risk Calculus for Sponsors
4
Pharmaceutical Executive Daily: Conflict in Middle East Disrupts Pharma Supply Chains
5